2018
DOI: 10.1055/a-0659-9864
|View full text |Cite
|
Sign up to set email alerts
|

Endoscopic biliary stenting: indications, choice of stents, and results: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline – Updated October 2017

Abstract: ESGE recommends against routine preoperative biliary drainage in patients with malignant extrahepatic biliary obstruction; preoperative biliary drainage should be reserved for patients with cholangitis, severe symptomatic jaundice (e. g., intense pruritus), or delayed surgery, or for before neoadjuvant chemotherapy in jaundiced patients. Strong recommendation, moderate quality evidence. ESGE recommends the endoscopic placement of a 10-mm diameter self-expandable metal stent (SEMS) for preoperative biliary drai… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

9
519
6
21

Year Published

2019
2019
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 518 publications
(555 citation statements)
references
References 262 publications
(217 reference statements)
9
519
6
21
Order By: Relevance
“…Endoscopic placement of a self‐expandable metal stent (SEMS) has been first‐line palliative treatment of nonresectable distal malignant biliary obstruction (MBO) because of longer duration of patency compared to plastic stents . Covered SEMS have emerged as an alternative to uncovered SEMS with the expectation of further prolonged patency through preventing tumor tissue and reactive epithelial hyperplasia from invading through the mesh wall .…”
Section: Introductionmentioning
confidence: 99%
“…Endoscopic placement of a self‐expandable metal stent (SEMS) has been first‐line palliative treatment of nonresectable distal malignant biliary obstruction (MBO) because of longer duration of patency compared to plastic stents . Covered SEMS have emerged as an alternative to uncovered SEMS with the expectation of further prolonged patency through preventing tumor tissue and reactive epithelial hyperplasia from invading through the mesh wall .…”
Section: Introductionmentioning
confidence: 99%
“…Third, our stenting period was 3–4 months that was shorter than that in other previous studies. The ideal duration of FCSEMS in benign stricture is not well known and still on debate . Before this study, we conducted pilot study comparing the efficacy and safety of 6‐month stenting versus 3‐month stenting .…”
Section: Discussionmentioning
confidence: 99%
“…However, limitations include a higher risk of migration. The European Society of Gastroenterology Endoscopy (ESGE) guidelines reinforce that multiple plastic stents (MPSs) and SEMSs are the standard of care currently for the treatment of BBSs (strong recommendation, moderate-quality evidence) [5]. Newer fully covered and intraductal SEMSs have antimigration properties to reduce the risk of stent migration [6].…”
Section: Introductionmentioning
confidence: 99%